
Overview
Agriculture firm's Q4 revenue missed analyst expectations
Operating EBITDA for Q4 decreased 15% yr/yr
Company remains on track for planned separation in H2 of 2026
Outlook
Corteva expects 2026 operating EBITDA to be $4.0 bln to $4.2 bln
Company anticipates 2026 operating EPS of $3.45 to $3.70 per share
Corteva sees mixed global agriculture outlook with pricing pressures in key regions
Result Drivers
SEED TECHNOLOGY - Demand for latest technology and productivity improvements drove Seed performance
CROP PROTECTION VOLUME - Volume growth in new products and biologicals supported Crop Protection results, despite pricing pressure
CASH GENERATION - Robust cash generation driven by earnings growth and efficient working capital management
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Miss | $3.91 bln | $4.24 bln (15 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the agricultural chemicals peer group is "buy"
Wall Street's median 12-month price target for Corteva Inc is $80.00, about 9.3% above its February 2 closing price of $73.20
The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago
Press Release: ID:nPn8PQYzKa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.